Purchases and Sales Made in Q3 2024 in Day One Biopharmaceuticals, Inc. (DAWN)
This table provides information about the institutional ownership of Day One Biopharmaceuticals, Inc. (DAWN) during Q3 2024. The information is specifically focused on institutions that hold shares of Day One Biopharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 08, 2024
Q3 2024
|
Pnc Financial Services Group, Inc.
Pittsburgh, PA |
BUY
|
- |
3New |
$38.2 - $48.1
|
3
$29.1
|
|
|
Nov 15, 2024
Q3 2024
|
Nomura Asset Management CO LTD
Tokyo, M0 |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 24, 2024
Q3 2024
|
Nisa Investment Advisors, LLC
|
SELL
|
- |
-63- 5.45% |
$801 - $1.01K
|
1.09K
$10.6K
|
|
|
Nov 15, 2024
Q3 2024
|
Continuum Advisory, LLC
Eagle, ID |
SELL
|
- |
-282- 21.04% |
$3.59K - $4.52K
|
1.06K
$10.3K
|
|
|
Oct 30, 2024
Q3 2024
|
Amalgamated Bank
New York, NY |
SELL
|
- |
-356- 16.65% |
$4.53K - $5.71K
|
1.78K
$17.3K
|
|
|
Nov 13, 2024
Q3 2024
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-457- 0.8% |
$5.81K - $7.33K
|
56.5K
$548K
|
|
|
Nov 14, 2024
Q3 2024
|
Macquarie Group LTD
Australia, C3 |
SELL
|
- |
-603- 0.55% |
$7.67K - $9.67K
|
110K
$1.07M
|
|
|
Nov 13, 2024
Q3 2024
|
Profund Advisors LLC
|
SELL
|
- |
-716- 2.59% |
$9.11K - $11.5K
|
26.9K
$261K
|
|
|
Oct 22, 2024
Q3 2024
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-793- 1.23% |
$10.1K - $12.7K
|
63.6K
$617K
|
|
|
Feb 28, 2025
Q3 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-1.36K- 2.36% |
$17.3K - $21.8K
|
56.3K
$546K
|
|
|
Nov 13, 2024
Q3 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-1.72K- 98.23% |
$21.9K - $27.6K
|
31
$301
|
|
|
Nov 14, 2024
Q3 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-3K- 0.11% |
$38.2K - $48.1K
|
2.82M
$27.4M
|
|
|
Oct 10, 2024
Q3 2024
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-3.03K- 19.79% |
$38.6K - $48.6K
|
12.3K
$119K
|
|
|
Nov 13, 2024
Q3 2024
|
Cetera Investment Advisers
Schaumburg, IL |
SELL
|
- |
-4.01K- 15.54% |
$51.1K - $64.3K
|
21.8K
$212K
|
|
|
Nov 14, 2024
Q3 2024
|
Mirae Asset Global Etfs Holdings Ltd.
Central, K3 |
SELL
|
- |
-4.23K- 11.07% |
$53.7K - $67.7K
|
33.9K
$329K
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Asset Management Americas Inc
Chicago, IL |
SELL
|
- |
-4.54K- 6.51% |
$57.7K - $72.7K
|
65.2K
$632K
|
|
|
Nov 14, 2024
Q3 2024
|
Point72 (Difc) LTD
Dubai, C0 |
SELL
|
- |
-7.85K- 87.3% |
$99.9K - $126K
|
1.14K
$11.1K
|
|
|
Oct 28, 2024
Q3 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-7.9K- 39.44% |
$100K - $127K
|
12.1K
$118K
|
|
|
Nov 12, 2024
Q3 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-8.14K- 9.53% |
$104K - $130K
|
77.3K
$750K
|
|
|
Nov 08, 2024
Q3 2024
|
Simplex Trading, LLC
|
SELL
|
- |
-10.2K- 58.45% |
$130K - $163K
|
7.24K
$70.2K
|
|
|
Nov 13, 2024
Q3 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-13.2K- 8.83% |
$168K - $212K
|
136K
$1.32M
|
|
|
Nov 14, 2024
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-18.3K- 51.24% |
$233K - $294K
|
17.4K
$169K
|
|
|
Feb 07, 2025
Q3 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-18.3K- 51.24% |
$233K - $294K
|
17.4K
$169K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-22.6K- 95.54% |
$287K - $362K
|
1.05K
$10.2K
|
|
|
Nov 14, 2024
Q3 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-26.4K- 29.02% |
$336K - $424K
|
64.7K
$627K
|
|
|
Nov 14, 2024
Q3 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-27.2K- 14.25% |
$346K - $436K
|
164K
$1.59M
|
|
|
Nov 13, 2024
Q3 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-37.9K- 7.12% |
$483K - $608K
|
495K
$4.8M
|
|
|
Nov 14, 2024
Q3 2024
|
Samsara Bio Capital, LLC
Palo Alto, CA |
SELL
|
- |
-49.1K- 25.0% |
$625K - $787K
|
147K
$1.43M
|
|
|
Nov 07, 2024
Q3 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-51.9K- 5.85% |
$660K - $832K
|
836K
$8.11M
|
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-54.5K- 13.73% |
$693K - $873K
|
342K
$3.32M
|
|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-61.3K- 36.52% |
$779K - $982K
|
106K
$1.03M
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-81.2K- 36.2% |
$1.03M - $1.3M
|
143K
$1.39M
|
|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-110K- 61.2% |
$1.4M - $1.76M
|
69.8K
$677K
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-129K- 6.77% |
$1.64M - $2.06M
|
1.77M
$17.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Driehaus Capital Management LLC
Chicago, IL |
SELL
|
- |
-180K- 25.44% |
$2.29M - $2.88M
|
527K
$5.11M
|
|
|
Nov 14, 2024
Q3 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-198K- 80.66% |
$2.51M - $3.17M
|
47.4K
$460K
|
|
|
Nov 14, 2024
Q3 2024
|
Deerfield Management Company, L.P. (Series C)
New York, NY |
SELL
|
- |
-305K- 10.45% |
$3.88M - $4.9M
|
2.62M
$25.4M
|
|
|
Nov 14, 2024
Q3 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-750K- 80.21% |
$9.54M - $12M
|
185K
$1.79M
|